Authors: MOORE RD FORTGANG I KERULY J CHAISSON RE

Citation: Rd. Moore et al., ADVERSE EVENTS FROM DRUG-THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE, The American journal of medicine, 101(1), 1996, pp. 34-40

Authors: GALLANT JE MOORE RD KERULY J RICHMAN DD CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T KESSLER H BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R CHAPMAN R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J LANE C TILSON H ANDREWS E SMILEY L

Citation: Je. Gallant et al., LACK OF ASSOCIATION BETWEEN ACYCLOVIR USE AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, The Journal of infectious diseases, 172(2), 1995, pp. 346-352

Authors: ALWOOD K KERULY J MOORERICE K STANTON DL CHAULK CP CHAISSON RE

Citation: K. Alwood et al., EFFECTIVENESS OF SUPERVISED, INTERMITTENT THERAPY FOR TUBERCULOSIS INHIV-INFECTED PATIENTS, AIDS, 8(8), 1994, pp. 1103-1108

Authors: GALLANT JE MOORE RD RICHMAN DD KERULY J CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J TILSON H SMILEY L

Citation: Je. Gallant et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, Archives of internal medicine, 154(5), 1994, pp. 566-572

Authors: GALLANT JE CHAISSON RE KERULY J MOORE RD

Citation: Je. Gallant et al., FACTORS ASSOCIATED WITH INCREASED RISK OF ACQUIRING CYTOMEGALOVIRUS DISEASE IN AIDS PATIENTS - REPLY, The Journal of infectious diseases, 168(4), 1993, pp. 1072-1072

Authors: ALWOOD K MOORERICE K KERULY J STANTON D CHAULK P CHAISSON RE

Citation: K. Alwood et al., EFFECTIVENESS OF SUPERVISED, INTERMITTENT THERAPY FOR TUBERCULOSIS INHIV-INFECTION, The American review of respiratory disease, 147(4), 1993, pp. 489-489